var data={"title":"Viral meningitis: Management, prognosis, and prevention in children","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Viral meningitis: Management, prognosis, and prevention in children</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/contributors\" class=\"contributor contributor_credentials\">Cecilia Di Pentima, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/contributors\" class=\"contributor contributor_credentials\">Sheldon L Kaplan, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/contributors\" class=\"contributor contributor_credentials\">Douglas R Nordli, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/contributors\" class=\"contributor contributor_credentials\">Carrie Armsby, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Apr 12, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The management, prognosis, and prevention of viral meningitis in children will be discussed here. The epidemiology, pathogenesis, clinical manifestations, diagnosis, and differential diagnosis are discussed separately. (See <a href=\"topic.htm?path=viral-meningitis-epidemiology-pathogenesis-and-etiology-in-children\" class=\"medical medical_review\">&quot;Viral meningitis: Epidemiology, pathogenesis, and etiology in children&quot;</a> and <a href=\"topic.htm?path=viral-meningitis-clinical-features-and-diagnosis-in-children\" class=\"medical medical_review\">&quot;Viral meningitis: Clinical features and diagnosis in children&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">OVERVIEW OF APPROACH</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Viral meningitis may be suspected on the basis of epidemiologic data, clinical features, and initial cerebrospinal (CSF) studies, but clinical features cannot reliably differentiate viral from bacterial meningitis; the CSF profiles of bacterial and viral meningitis overlap considerably (<a href=\"image.htm?imageKey=ID%2F76324\" class=\"graphic graphic_table graphicRef76324 \">table 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The diagnosis of viral meningitis requires negative CSF culture for routine bacterial pathogens and positive identification of a viral pathogen in the CSF or other patient samples. (See <a href=\"topic.htm?path=viral-meningitis-clinical-features-and-diagnosis-in-children#H19\" class=\"medical medical_review\">&quot;Viral meningitis: Clinical features and diagnosis in children&quot;, section on 'Diagnosis'</a>.)</p><p>Pending results of CSF cultures and virologic studies, the results of the initial evaluation can be used to make a provisional diagnosis of bacterial meningitis, viral meningitis, or unclear etiology (<a href=\"image.htm?imageKey=ID%2F76324\" class=\"graphic graphic_table graphicRef76324 \">table 1</a>). The provisional diagnosis is one of several considerations in the initial management.</p><p>Indications for hospitalization may include [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/3,4\" class=\"abstract_t\">3,4</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ill-appearance or signs of encephalitis (eg, altered mental status, behavior, or personality; motor or sensory deficits; speech or movement disorders; hemiparesis; flaccid paralysis; paresthesias; seizures) (see <a href=\"topic.htm?path=acute-viral-encephalitis-in-children-clinical-manifestations-and-diagnosis#H2\" class=\"medical medical_review\">&quot;Acute viral encephalitis in children: Clinical manifestations and diagnosis&quot;, section on 'Clinical features'</a> and <a href=\"topic.htm?path=paraneoplastic-and-autoimmune-encephalitis\" class=\"medical medical_review\">&quot;Paraneoplastic and autoimmune encephalitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Need for empiric antimicrobial therapy (see <a href=\"#H9\" class=\"local\">'Empiric antibiotics'</a> below)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Need for intravenous hydration or aggressive pain control (see <a href=\"#H7\" class=\"local\">'Supportive care'</a> below)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immunocompromised host</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Age younger than one year</p><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Suspected bacterial meningitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with positive Gram stain, CSF white blood cell (WBC) count <span class=\"nowrap\">&gt;1000/microL</span> with a predominance of neutrophils (polymorphonuclear leukocytes, PMN), and CSF glucose concentration &lt;40 <span class=\"nowrap\">mg/dL</span> (2.2 <span class=\"nowrap\">mmol/L),</span> are likely to have bacterial meningitis. They should be hospitalized and treated accordingly (<a href=\"image.htm?imageKey=PEDS%2F74865\" class=\"graphic graphic_algorithm graphicRef74865 \">algorithm 1</a>). (See <a href=\"topic.htm?path=bacterial-meningitis-in-children-older-than-one-month-treatment-and-prognosis#H9\" class=\"medical medical_review\">&quot;Bacterial meningitis in children older than one month: Treatment and prognosis&quot;, section on 'Immediate management'</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Suspected viral meningitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with CSF WBC count <span class=\"nowrap\">&lt;500/microL</span> with &gt;50 percent mononuclear cells, CSF protein &lt;80 to 100 <span class=\"nowrap\">mg/dL,</span> normal CSF glucose, and negative Gram stain are likely to have viral meningitis (<a href=\"image.htm?imageKey=ID%2F76324\" class=\"graphic graphic_table graphicRef76324 \">table 1</a>). Epidemiologic and clinical data that support the provisional diagnosis of viral meningitis include associated herpangina, enterovirus disease in the community in the summer or fall, and improvement in clinical illness after lumbar puncture (LP) [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/5,6\" class=\"abstract_t\">5,6</a>].</p><p>Decisions regarding empiric antibiotic treatment versus observation of children with suspected viral meningitis while awaiting culture results are made on a case-by-case basis. (See <a href=\"#H9\" class=\"local\">'Empiric antibiotics'</a> below.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Unclear etiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The etiology is unclear when the clinical and laboratory features of bacterial and viral infections overlap. We suggest that such children be treated with empiric therapy pending additional information (eg, results of culture, PCR, or repeat lumbar puncture). (See <a href=\"#H9\" class=\"local\">'Empiric antibiotics'</a> below.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Repeat LP</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When one of the features suggestive of bacterial meningitis is a predominance of neutrophils rather than mononuclear cells in the CSF differential, and assuming that CSF analysis for EV by PCR is negative, observing a patient with or without administration of antimicrobials and repeating the LP 6 to 24 hours after the initial procedure may help clarify the likely etiology [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/4,5,7-9\" class=\"abstract_t\">4,5,7-9</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A shift to mononuclear predominance supports a viral process.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Persistent PMN predominance supports a bacterial process. However, persistence of PMN also occurs with viral meningitis and should not be used as the only criterion to distinguish between bacterial and viral disease [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">SUPPORTIVE CARE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Supportive care for children with viral meningitis may include [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/3\" class=\"abstract_t\">3</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rest in a quiet, dimly lit room</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">Acetaminophen</a> for headache, pain, and fever; <a href=\"topic.htm?path=aspirin-pediatric-drug-information\" class=\"drug drug_pediatric\">aspirin</a> should be avoided because of its association with Reye syndrome</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intravenous fluid therapy if prolonged emesis has resulted in hypovolemia. Careful attention to fluid balance is an important aspect of supportive care. The need for fluid repletion must be balanced against the risk of inappropriate secretion of antidiuretic hormone.</p><p/><p>Neonates and immunocompromised hosts may require aggressive supportive care for disseminated disease (eg, myocarditis, pericarditis, hepatitis, coagulopathy), particularly with enterovirus or herpes simplex virus (HSV) infection [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention#H3\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Management and prevention&quot;, section on 'Supportive measures'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">EMPIRIC THERAPY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While awaiting the results of bacterial cultures, empiric antimicrobial therapy should be provided to patients in whom bacterial meningitis is suspected or cannot be excluded. Empiric treatment for HSV, tuberculosis, and various other infections also may be warranted in patients who are severely ill or have clinical features suggestive of these infections.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Empiric antibiotics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with suspected bacterial meningitis or meningitis of unclear etiology should be hospitalized and treated with appropriate empiric therapy. (See <a href=\"topic.htm?path=bacterial-meningitis-in-children-older-than-one-month-treatment-and-prognosis#H13\" class=\"medical medical_review\">&quot;Bacterial meningitis in children older than one month: Treatment and prognosis&quot;, section on 'Empiric therapy'</a>.)</p><p>The decision to treat children with suspected viral meningitis with empiric antibiotics while awaiting bacterial cultures is individualized based upon epidemiology and clinical factors. Important considerations include the season, age and clinical status of the child, exposure history, and findings of the initial evaluation. In view of the serious consequences of delayed treatment for bacterial meningitis, the threshold to initiate empiric antibiotic therapy should be relatively low.</p><p>We recommend empiric antibiotic therapy while awaiting bacterial culture results in the following patients with suspected viral meningitis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Those who are &lt;3 months of age (see <a href=\"topic.htm?path=febrile-infant-younger-than-90-days-of-age-outpatient-evaluation\" class=\"medical medical_review\">&quot;Febrile infant (younger than 90 days of age): Outpatient evaluation&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Those who are severely ill or immunocompromised</p><p/><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Choice of agent</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Empiric antibiotics should be chosen to cover the most likely bacterial pathogens in the individual host. In severely ill patients, empiric therapy for unusual bacterial pathogens also may be warranted. Glucocorticoids, when administered initially to children who were ultimately diagnosed with aseptic meningitis, were not shown to produce detectable adverse outcomes [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/10\" class=\"abstract_t\">10</a>]. (See <a href=\"topic.htm?path=bacterial-meningitis-in-the-neonate-treatment-and-outcome#H4\" class=\"medical medical_review\">&quot;Bacterial meningitis in the neonate: Treatment and outcome&quot;, section on 'Empiric therapy'</a> and <a href=\"topic.htm?path=bacterial-meningitis-in-children-older-than-one-month-treatment-and-prognosis#H15\" class=\"medical medical_review\">&quot;Bacterial meningitis in children older than one month: Treatment and prognosis&quot;, section on 'Empiric regimen'</a> and <a href=\"topic.htm?path=bacterial-meningitis-in-children-dexamethasone-and-other-measures-to-prevent-neurologic-complications#H3\" class=\"medical medical_review\">&quot;Bacterial meningitis in children: Dexamethasone and other measures to prevent neurologic complications&quot;, section on 'Dexamethasone'</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Duration of therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients who improve symptomatically, empiric antibiotic therapy is usually discontinued when the bacterial culture is negative after 24 to 48 hours <span class=\"nowrap\">and/or</span> an alternative diagnosis is made (eg, by viral polymerase chain reaction [PCR]) [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/3\" class=\"abstract_t\">3</a>]. In patients with persistent symptoms, additional evaluation may be necessary. (See <a href=\"#H15\" class=\"local\">'Persistent symptoms'</a> below.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Empiric antivirals</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Depending upon the clinical scenario and severity of illness, empiric treatment with antiviral therapy may be warranted for certain patients.</p><p>We recommend empiric therapy with <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> for children with CSF pleocytosis who have encephalitis, or focal findings on examination, imaging, or electroencephalography [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/3\" class=\"abstract_t\">3</a>]. Acyclovir also may be warranted when HSV or varicella-zoster virus (VZV) are possible etiologies in an immunocompromised patient. (See <a href=\"#H14\" class=\"local\">'Specific therapy'</a> below.)</p><p>In the event that IV <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> is not available (eg, during a shortage, when existing supplies are reserved for neonates with HSV, individuals with HSV encephalitis, and pregnant women), alternatives to IV acyclovir are discussed separately. (See <a href=\"topic.htm?path=acyclovir-an-overview#H620875503\" class=\"medical medical_review\">&quot;Acyclovir: An overview&quot;, section on 'If there is an acyclovir shortage'</a>.) </p><p>Decisions regarding the use of empiric <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> in infants with CSF pleocytosis who are younger than 28 days must be made on a case-by-case basis. Clinical features suggestive of HSV infection include mucocutaneous vesicles (<a href=\"image.htm?imageKey=PEDS%2F75059%7EPEDS%2F56041%7EPEDS%2F78598\" class=\"graphic graphic_picture graphicRef75059 graphicRef56041 graphicRef78598 \">picture 1A-C</a>), seizures, lethargy, respiratory distress, thrombocytopenia, coagulopathy, blood oozing from intravascular catheter sites, hypothermia, sepsis-like illness, hepatomegaly, ascites, or elevated transaminases (<a href=\"image.htm?imageKey=PEDS%2F67814\" class=\"graphic graphic_figure graphicRef67814 \">figure 1</a>). (See <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis#H4\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Clinical features and diagnosis&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention#H5\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Management and prevention&quot;, section on 'Indications'</a>.)</p><p>Information about the relative prevalence of HSV and bacterial meningitis in neonates with CSF pleocytosis is provided by a retrospective review of 5817 neonates evaluated in the emergency department and admitted to a tertiary-care children's hospital over five years (2001-2005) (<a href=\"image.htm?imageKey=PEDS%2F57037\" class=\"graphic graphic_table graphicRef57037 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/11\" class=\"abstract_t\">11</a>].</p><p>The findings are summarized as follows:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The overall prevalence of HSV infection was similar to that of bacterial meningitis (0.2 and 0.4 percent, respectively).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>All 10 patients with confirmed HSV infection had clinical features suggestive of HSV (eg, rash, elevated liver transaminases, sepsis-like picture).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In neonates with CSF pleocytosis, predominance of PMNs (&gt;50 percent) in the CSF was associated with bacterial meningitis, but predominance of mononuclear cells (&gt;50 percent) in the CSF was not associated with HSV. Nonetheless, a predominance of PMN in the CSF did not absolutely exclude the possibility of HSV (95% CI 0-5.4).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Enteroviral meningitis was more likely than HSV in febrile neonates with CSF pleocytosis (20 cases versus 1 case, respectively, during enteroviral season and six cases versus one case during nonenteroviral season).</p><p/><p>As illustrated by the editorials accompanying publication of this review, controversy exists regarding the empiric use of <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> in neonates with CSF pleocytosis and no other manifestations suggestive of HSV [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/11-13\" class=\"abstract_t\">11-13</a>]. On the one hand, acyclovir is an effective therapy for an uncommon, but potentially devastating, infection that may have a subtle presentation and occurs with approximately the same prevalence as bacterial meningitis [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/12,14\" class=\"abstract_t\">12,14</a>]. On the other hand, empiric acyclovir therapy may be associated with adverse effects or prolong hospitalization while awaiting results of viral cultures or HSV PCR [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/13,15\" class=\"abstract_t\">13,15</a>]. (See <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention#H4\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Management and prevention&quot;, section on 'Acyclovir therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Duration</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients who are clinically improved, empiric <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> may be discontinued when HSV PCR and cultures are negative or an alternative diagnosis is made (eg, by enteroviral PCR). Viral isolates usually grow in tissue culture by four to eight days. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection#H25\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis#H11\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Clinical features and diagnosis&quot;, section on 'Evaluation and diagnosis'</a>.)</p><p>In patients with persistent symptoms, continuation of empiric <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> <span class=\"nowrap\">and/or</span> additional evaluation may be necessary. (See <a href=\"#H15\" class=\"local\">'Persistent symptoms'</a> below.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">SPECIFIC THERAPY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most cases of viral meningitis are treated symptomatically. (See <a href=\"#H7\" class=\"local\">'Supportive care'</a> above.)</p><p>Selected antiviral agents have been tried against some of the viral pathogens.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Enteroviruses (EV) &ndash; Therapeutic options for serious EV infection are limited. This is discussed in greater detail separately. (See <a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention#H1188943006\" class=\"medical medical_review\">&quot;Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention&quot;, section on 'Treatment'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herpes simplex virus (HSV) &ndash; Although the outcome of HSV meningitis <strong>without</strong> encephalitis is usually excellent even without antiviral therapy, <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> can be used to hasten recovery [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/3,16\" class=\"abstract_t\">3,16</a>]. Acyclovir is dosed as follows [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/17,18\" class=\"abstract_t\">17,18</a>]:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For neonatal HSV, 60 <span class=\"nowrap\">mg/kg</span> per day intravenously (IV) divided every 8 hours, for a minimum of 21 days (see <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention#H4\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Management and prevention&quot;, section on 'Acyclovir therapy'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For CNS infections in children aged 3 months to 11 years, 30 to 45 <span class=\"nowrap\">mg/kg</span> per day IV, divided every 8 hours, for a minimum of 14 to 21 days</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For CNS infections in children &ge;12 years old, 30 <span class=\"nowrap\">mg/kg</span> per day IV, divided every 8 hours, for a minimum of 14 to 21 days</p><p/><p class=\"bulletIndent1\">In the event that IV <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> is not available (eg, during a shortage, when existing supplies are reserved for neonates with HSV, individuals with HSV encephalitis, and pregnant women), alternatives to IV acyclovir are discussed separately. (See <a href=\"topic.htm?path=acyclovir-an-overview#H620875503\" class=\"medical medical_review\">&quot;Acyclovir: An overview&quot;, section on 'If there is an acyclovir shortage'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Varicella-zoster virus (VZV) &ndash; Treatment with <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> may improve outcomes, although data are limited in pediatric patients [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/19\" class=\"abstract_t\">19</a>]. Treatment of VZV is discussed in greater detail separately. (See <a href=\"topic.htm?path=treatment-of-herpes-zoster-in-the-immunocompetent-host#H1703276533\" class=\"medical medical_review\">&quot;Treatment of herpes zoster in the immunocompetent host&quot;, section on 'Neurologic complications'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ebstein-Barr virus (EBV) &ndash; EBV infection rarely requires more than supportive therapy. Even in clinical situations where an antiviral treatment would be desirable, it is not clear that EBV responds. This is discussed in greater detail separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-epstein-barr-virus-infection#H26\" class=\"medical medical_review\">&quot;Clinical manifestations and treatment of Epstein-Barr virus infection&quot;, section on 'Treatment and prevention'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cytomegalovirus (CMV) &ndash; CMV infection in immunocompromised children is treated with <a href=\"topic.htm?path=ganciclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">ganciclovir</a>. Treatment may also be warranted in immunocompetent children with serious symptomatic CMV infection; however, data are limited. Treatment of CMV in children is discussed in detail separately. (See <a href=\"topic.htm?path=overview-of-cytomegalovirus-infections-in-children#H19\" class=\"medical medical_review\">&quot;Overview of cytomegalovirus infections in children&quot;, section on 'Treatment'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arboviruses and LCMV &ndash; Most arboviral and LCMV infections of the CNS are treated symptomatically. Investigative therapies for WNV are discussed separately. (See <a href=\"topic.htm?path=arthropod-borne-encephalitides\" class=\"medical medical_review\">&quot;Arthropod-borne encephalitides&quot;</a> and <a href=\"topic.htm?path=treatment-and-prevention-of-west-nile-virus-infection\" class=\"medical medical_review\">&quot;Treatment and prevention of West Nile virus infection&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Influenza &ndash; For patients with confirmed or suspected influenza who are hospitalized or who have severe, complicated, or progressive illness, antiviral treatment with <a href=\"topic.htm?path=oseltamivir-pediatric-drug-information\" class=\"drug drug_pediatric\">oseltamivir</a> or <a href=\"topic.htm?path=zanamivir-pediatric-drug-information\" class=\"drug drug_pediatric\">zanamivir</a> should be started as soon as possible after symptom onset. Treatment of influenza infection in children is discussed in greater detail separately. (See <a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-and-treatment-with-antiviral-drugs#H20\" class=\"medical medical_review\">&quot;Seasonal influenza in children: Prevention and treatment with antiviral drugs&quot;, section on 'Antiviral therapy'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">PERSISTENT SYMPTOMS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When symptoms persist or worsen in patients with bacterial culture-negative aseptic meningitis, nonviral causes must be considered (<a href=\"image.htm?imageKey=PEDS%2F80651\" class=\"graphic graphic_table graphicRef80651 \">table 3</a>). Additional evaluation may include [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/5,20\" class=\"abstract_t\">5,20</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Repeat lumbar puncture with removal of 3 to 5 mL of CSF (if possible) for fungal and mycobacterial cultures.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Imaging of the CNS and sinuses with MRI or CT to look for parameningeal infection and acute disseminated encephalomyelitis. (See <a href=\"topic.htm?path=acute-disseminated-encephalomyelitis-in-children-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evaluation for Lyme disease, ehrlichiosis, rickettsial infection. (See <a href=\"topic.htm?path=diagnosis-of-lyme-disease\" class=\"medical medical_review\">&quot;Diagnosis of Lyme disease&quot;</a> and <a href=\"topic.htm?path=human-ehrlichiosis-and-anaplasmosis\" class=\"medical medical_review\">&quot;Human ehrlichiosis and anaplasmosis&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rocky-mountain-spotted-fever\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Rocky Mountain spotted fever&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evaluation for parasitic infection. (See <a href=\"topic.htm?path=cysticercosis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Cysticercosis: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=trichinellosis\" class=\"medical medical_review\">&quot;Trichinellosis&quot;</a> and <a href=\"topic.htm?path=toxoplasmosis-in-immunocompetent-hosts\" class=\"medical medical_review\">&quot;Toxoplasmosis in immunocompetent hosts&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most children with viral meningitis recover completely [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/1,21,22\" class=\"abstract_t\">1,21,22</a>]. Some may complain of several weeks of fatigue, irritability, decreased concentration, muscle weakness and spasm, and incoordination after the acute illness [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/22\" class=\"abstract_t\">22</a>].</p><p>Prognosis depends upon the age of the child and the etiologic agent. Enteroviral meningitis typically has a benign clinical course, which by definition lacks the neurologic abnormalities that characterize encephalitis or myelitis [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/23\" class=\"abstract_t\">23</a>]. The morbidity and mortality are not precisely known, as widespread disease occurs each year, and EV meningitis is not a reportable condition. For particularly susceptible neonatal or immune-compromised hosts, the rates of sequelae and mortality may be as high as 74 and 10 percent, respectively. When death occurs, it is usually due to hepatic failure (with echoviruses) or myocarditis (coxsackieviruses) [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/24,25\" class=\"abstract_t\">24,25</a>].</p><p>The duration of symptoms in children is usually less than one week; many report clinical improvement after lumbar puncture [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/6,23\" class=\"abstract_t\">6,23</a>]. Adolescents and adults may have a prolonged convalescent stage, with symptoms persisting for several weeks [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/26\" class=\"abstract_t\">26</a>].</p><p>Children with EV meningitis generally recover without neurologic sequelae. Several studies have suggested possible long-term neurologic, cognitive, developmental, and language abnormalities in young children following EV meningitis; however, these observations have been inconsistent [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/21,27-29\" class=\"abstract_t\">21,27-29</a>]. EV71 CNS infection with cardiopulmonary involvement has been associated with neurologic sequelae, including delayed development and reduced cognitive function [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/30\" class=\"abstract_t\">30</a>].</p><p>The immune clearance of EV is dependent upon an appropriate antibody-mediated response. Individuals with hereditary or acquired defects in B lymphocyte function (eg, agammaglobulinemia, hypogammaglobulinemia, common variable immunodeficiency) may develop persistent, sometimes fatal, chronic meningitis or meningoencephalitis [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention#H17\" class=\"medical medical_review\">&quot;Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention&quot;, section on 'Immunocompromised patients'</a>.)</p><p>Sequelae of Western equine encephalitis (WEE) viral infection are mainly associated with encephalitis. These include fatigue, irritability, headaches, and tremors that can last up to two years [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/32\" class=\"abstract_t\">32</a>]. The overall case fatality rate is 3 to 4 percent [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/32\" class=\"abstract_t\">32</a>]. Neonates and young infants are more severely affected. More than 50 percent of neonates develop severe motor damage or cognitive disabilities following WEE virus CNS infections. Older patients with meningitis have a good prognosis. (See <a href=\"topic.htm?path=arthropod-borne-encephalitides#H11\" class=\"medical medical_review\">&quot;Arthropod-borne encephalitides&quot;, section on 'Western equine encephalitis virus'</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h1\">FOLLOW-UP</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Assessment for muscular weakness should be performed several weeks after the symptoms of viral meningitis have improved [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/30,33\" class=\"abstract_t\">30,33</a>]. (See <a href=\"topic.htm?path=hearing-impairment-in-children-evaluation\" class=\"medical medical_review\">&quot;Hearing impairment in children: Evaluation&quot;</a>.)</p><p>Long-term follow-up of young infants should include regular developmental surveillance, particularly during the early school years [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/9,22,30\" class=\"abstract_t\">9,22,30</a>]. (See <a href=\"topic.htm?path=developmental-behavioral-surveillance-and-screening-in-primary-care\" class=\"medical medical_review\">&quot;Developmental-behavioral surveillance and screening in primary care&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">PREVENTION</span></p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Hygiene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Simple hygienic measures, such as hand washing, particularly after diaper changing, are important to prevent the spread of enteroviruses. (See <a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention#H3549546259\" class=\"medical medical_review\">&quot;Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention&quot;, section on 'Prevention'</a>.)</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Vaccines</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vaccines are available to prevent poliovirus, influenza, rabies, and some arboviruses (eg, Japanese encephalitis virus, Tick-borne encephalitis). Target groups for these vaccines are discussed separately. (See <a href=\"topic.htm?path=poliovirus-vaccination\" class=\"medical medical_review\">&quot;Poliovirus vaccination&quot;</a> and <a href=\"topic.htm?path=rabies-immune-globulin-and-vaccine\" class=\"medical medical_review\">&quot;Rabies immune globulin and vaccine&quot;</a> and <a href=\"topic.htm?path=immunizations-for-travel\" class=\"medical medical_review\">&quot;Immunizations for travel&quot;</a> and <a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-with-vaccines#H7\" class=\"medical medical_review\">&quot;Seasonal influenza in children: Prevention with vaccines&quot;, section on 'Target groups'</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Personal protection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Personal protection measures to avoid mosquito and tick exposure are a mainstay of prevention. A variety of insect repellants are available. (See <a href=\"topic.htm?path=prevention-of-arthropod-and-insect-bites-repellents-and-other-measures\" class=\"medical medical_review\">&quot;Prevention of arthropod and insect bites: Repellents and other measures&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Infection control</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When children are hospitalized with aseptic meningitis, contact precautions are indicated for the duration of illness [<a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/34\" class=\"abstract_t\">34</a>]. (See <a href=\"topic.htm?path=infection-prevention-precautions-for-preventing-transmission-of-infection#H954996324\" class=\"medical medical_review\">&quot;Infection prevention: Precautions for preventing transmission of infection&quot;, section on 'Contact precautions'</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, 'The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=meningitis-in-children-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Meningitis in children (The Basics)&quot;</a> and <a href=\"topic.htm?path=viral-meningitis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Viral meningitis (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topic (see <a href=\"topic.htm?path=meningitis-in-children-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Meningitis in children (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pending results of CSF cultures and virologic studies, the results of the initial evaluation can be used to make a provisional diagnosis of bacterial meningitis, viral meningitis, or unclear etiology (<a href=\"image.htm?imageKey=ID%2F76324\" class=\"graphic graphic_table graphicRef76324 \">table 1</a>). The provisional diagnosis is one of several considerations in the initial management. (See <a href=\"#H2\" class=\"local\">'Overview of approach'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>While awaiting the results of bacterial cultures, empiric antimicrobial therapy for bacterial meningitis should be provided to patients in whom bacterial meningitis is suspected or cannot be excluded. (See <a href=\"#H8\" class=\"local\">'Empiric therapy'</a> above and <a href=\"topic.htm?path=bacterial-meningitis-in-children-older-than-one-month-treatment-and-prognosis#H13\" class=\"medical medical_review\">&quot;Bacterial meningitis in children older than one month: Treatment and prognosis&quot;, section on 'Empiric therapy'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The decision to treat children with suspected viral meningitis with empiric antibiotics while awaiting bacterial cultures is individualized based on epidemiology and clinical factors. We recommend empiric antibiotic therapy while awaiting bacterial culture results in children who are &lt;3 months of age, severely ill, or immunocompromised (<a href=\"grade.htm?i=2\" class=\"grade\">Grade 1B</a>). (See <a href=\"#H9\" class=\"local\">'Empiric antibiotics'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In children with suspected viral meningitis who improve symptomatically, empiric antibiotic therapy is usually discontinued when the bacterial culture is negative after 24 to 48 hours <span class=\"nowrap\">and/or</span> an alternative diagnosis is made. (See <a href=\"#H11\" class=\"local\">'Duration of therapy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We recommend empiric therapy with <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> for children with CSF pleocytosis who have encephalitis or focal findings on examination, imaging, or electroencephalography (<a href=\"grade.htm?i=2\" class=\"grade\">Grade 1B</a>). (See <a href=\"#H12\" class=\"local\">'Empiric antivirals'</a> above and <a href=\"topic.htm?path=herpes-simplex-virus-type-1-encephalitis#H19\" class=\"medical medical_review\">&quot;Herpes simplex virus type 1 encephalitis&quot;, section on 'Treatment'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In patients who improve symptomatically, empiric <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> may be discontinued when HSV PCR and cultures are negative <span class=\"nowrap\">and/or</span> an alternative diagnosis is made (eg, by enteroviral PCR). (See <a href=\"#H12\" class=\"local\">'Empiric antivirals'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>When symptoms persist or worsen, nonviral causes of aseptic meningitis must be considered (<a href=\"image.htm?imageKey=PEDS%2F80651\" class=\"graphic graphic_table graphicRef80651 \">table 3</a>). Additional evaluation may be necessary (see <a href=\"#H15\" class=\"local\">'Persistent symptoms'</a> above).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Follow-up of children with aseptic meningitis includes assessment for muscular weakness and developmental abnormalities. (See <a href=\"#H17\" class=\"local\">'Follow-up'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/1\" class=\"nounderline abstract_t\">Logan SA, MacMahon E. Viral meningitis. BMJ 2008; 336:36.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/2\" class=\"nounderline abstract_t\">Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 2000; 105:316.</a></li><li class=\"breakAll\">Abzug MJ. Viral meningitis and encephalitis. In: Current Pediatric Therapy, 18th, Burg FD, Ingelfinger JR, Polin RA, Gershon AA (Eds), Saunders, Philadelphia 2006. p.810.</li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/4\" class=\"nounderline abstract_t\">Singer JI, Maur PR, Riley JP, Smith PB. Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J Pediatr 1980; 96:559.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/5\" class=\"nounderline abstract_t\">Overall JC Jr. Is it bacterial or viral? Laboratory differentiation. Pediatr Rev 1993; 14:251.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/6\" class=\"nounderline abstract_t\">Jaffe M, Srugo I, Tirosh E, et al. The ameliorating effect of lumbar puncture in viral meningitis. Am J Dis Child 1989; 143:682.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/7\" class=\"nounderline abstract_t\">Feigin RD, Shackelford PG. Value of repeat lumbar puncture in the differential diagnosis of meningitis. N Engl J Med 1973; 289:571.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/8\" class=\"nounderline abstract_t\">Amir J, Harel L, Frydman M, et al. Shift of cerebrospinal polymorphonuclear cell percentage in the early stage of aseptic meningitis. J Pediatr 1991; 119:938.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/9\" class=\"nounderline abstract_t\">Wilfert CM, Lehrman SN, Katz SL. Enteroviruses and meningitis. Pediatr Infect Dis 1983; 2:333.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/10\" class=\"nounderline abstract_t\">Waagner DC, Kennedy WA, Hoyt MJ, McCracken GH Jr. Lack of adverse effects of dexamethasone therapy in aseptic meningitis. Pediatr Infect Dis J 1990; 9:922.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/11\" class=\"nounderline abstract_t\">Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008; 153:164.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/12\" class=\"nounderline abstract_t\">Long SS. In defense of empiric acyclovir therapy in certain neonates. J Pediatr 2008; 153:157.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/13\" class=\"nounderline abstract_t\">Kimberlin DW. When should you initiate acyclovir therapy in a neonate? J Pediatr 2008; 153:155.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/14\" class=\"nounderline abstract_t\">Long SS, Pool TE, Vodzak J, et al. Herpes simplex virus infection in young infants during 2 decades of empiric acyclovir therapy. Pediatr Infect Dis J 2011; 30:556.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/15\" class=\"nounderline abstract_t\">Shah SS, Volk J, Mohamad Z, et al. Herpes simplex virus testing and hospital length of stay in neonates and young infants. J Pediatr 2010; 156:738.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/16\" class=\"nounderline abstract_t\">Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis 1998; 26:541.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/17\" class=\"nounderline abstract_t\">Kimberlin DW. Acyclovir Dosing in the Neonatal Period and Beyond. J Pediatric Infect Dis Soc 2013; 2:179.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Herpes simplex. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.432.</li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/19\" class=\"nounderline abstract_t\">Kaewpoowat Q, Salazar L, Aguilera E, et al. Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection 2016; 44:337.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/20\" class=\"nounderline abstract_t\">Malcom BS, Eiden JJ, Hendley JO. ECHO virus type 9 meningitis simulating tuberculous meningitis. Pediatrics 1980; 65:725.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/21\" class=\"nounderline abstract_t\">Rorabaugh ML, Berlin LE, Heldrich F, et al. Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 1993; 92:206.</a></li><li class=\"breakAll\">Bronstein DE, Glaser CA. Aseptic meningitis and viral meningitis. In: Feigin and Cherry&rsquo;s Textbook of Pediatric Infectious Diseases, 7th, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2014. p.484.</li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/23\" class=\"nounderline abstract_t\">Rotbart HA. Viral meningitis. Semin Neurol 2000; 20:277.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/24\" class=\"nounderline abstract_t\">Kaplan MH, Klein SW, McPhee J, Harper RG. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 1983; 5:1019.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/25\" class=\"nounderline abstract_t\">Modlin JF. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis 1986; 8:918.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/26\" class=\"nounderline abstract_t\">Sawyer MH. Enterovirus infections: diagnosis and treatment. Semin Pediatr Infect Dis 2002; 13:40.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/27\" class=\"nounderline abstract_t\">Wilfert CM, Thompson RJ Jr, Sunder TR, et al. Longitudinal assessment of children with enteroviral meningitis during the first three months of life. Pediatrics 1981; 67:811.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/28\" class=\"nounderline abstract_t\">Sells CJ, Carpenter RL, Ray CG. Sequelae of central-nervous-system enterovirus infections. N Engl J Med 1975; 293:1.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/29\" class=\"nounderline abstract_t\">Bergman I, Painter MJ, Wald ER, et al. Outcome in children with enteroviral meningitis during the first year of life. J Pediatr 1987; 110:705.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/30\" class=\"nounderline abstract_t\">Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 2007; 356:1226.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/31\" class=\"nounderline abstract_t\">McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987; 9:334.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/32\" class=\"nounderline abstract_t\">Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994; 7:89.</a></li><li><a href=\"https://www.uptodate.com/contents/viral-meningitis-management-prognosis-and-prevention-in-children/abstract/33\" class=\"nounderline abstract_t\">Bao X, Wong V. Brainstem auditory-evoked potential evaluation in children with meningitis. Pediatr Neurol 1998; 19:109.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Enterovirus (nonpoliovirus). In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.333.</li></ol></div><div id=\"topicVersionRevision\">Topic 6028 Version 24.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H24\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">OVERVIEW OF APPROACH</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Suspected bacterial meningitis</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Suspected viral meningitis</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Unclear etiology</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">- Repeat LP</a></li></ul></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">SUPPORTIVE CARE</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">EMPIRIC THERAPY</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Empiric antibiotics</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">- Choice of agent</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Duration of therapy</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">Empiric antivirals</a><ul><li><a href=\"#H13\" id=\"outline-link-H13\">- Duration</a></li></ul></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">SPECIFIC THERAPY</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">PERSISTENT SYMPTOMS</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">PROGNOSIS</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">FOLLOW-UP</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">PREVENTION</a><ul><li><a href=\"#H19\" id=\"outline-link-H19\">Hygiene</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Vaccines</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Personal protection</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Infection control</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H15886538\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/6028|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/74865\" class=\"graphic graphic_algorithm\">- Management of suspected meningitis in children</a></li></ul></li><li><div id=\"PEDS/6028|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/67814\" class=\"graphic graphic_figure\">- Neonatal HSV SSx</a></li></ul></li><li><div id=\"PEDS/6028|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/75059\" class=\"graphic graphic_picture\">- Neonatal herpes simplex virus neck vesicles</a></li><li><a href=\"image.htm?imageKey=PEDS/56041\" class=\"graphic graphic_picture\">- Neonatal HSV scalp vesicles</a></li><li><a href=\"image.htm?imageKey=PEDS/78598\" class=\"graphic graphic_picture\">- Neonatal herpes simplex virus eye vesicles</a></li></ul></li><li><div id=\"PEDS/6028|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/76324\" class=\"graphic graphic_table\">- CSF analysis in CNS infections</a></li><li><a href=\"image.htm?imageKey=PEDS/57037\" class=\"graphic graphic_table\">- Prevalence of HSV vs bacterial meningitis in neonates</a></li><li><a href=\"image.htm?imageKey=PEDS/80651\" class=\"graphic graphic_table\">- Etiology aseptic meningitis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-disseminated-encephalomyelitis-in-children-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-viral-encephalitis-in-children-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute viral encephalitis in children: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acyclovir-an-overview\" class=\"medical medical_review\">Acyclovir: An overview</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=arthropod-borne-encephalitides\" class=\"medical medical_review\">Arthropod-borne encephalitides</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-meningitis-in-children-older-than-one-month-treatment-and-prognosis\" class=\"medical medical_review\">Bacterial meningitis in children older than one month: Treatment and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-meningitis-in-children-dexamethasone-and-other-measures-to-prevent-neurologic-complications\" class=\"medical medical_review\">Bacterial meningitis in children: Dexamethasone and other measures to prevent neurologic complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-meningitis-in-the-neonate-treatment-and-outcome\" class=\"medical medical_review\">Bacterial meningitis in the neonate: Treatment and outcome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rocky-mountain-spotted-fever\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Rocky Mountain spotted fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of herpes simplex virus type 1 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-epstein-barr-virus-infection\" class=\"medical medical_review\">Clinical manifestations and treatment of Epstein-Barr virus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cysticercosis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cysticercosis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=developmental-behavioral-surveillance-and-screening-in-primary-care\" class=\"medical medical_review\">Developmental-behavioral surveillance and screening in primary care</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-lyme-disease\" class=\"medical medical_review\">Diagnosis of Lyme disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=febrile-infant-younger-than-90-days-of-age-outpatient-evaluation\" class=\"medical medical_review\">Febrile infant (younger than 90 days of age): Outpatient evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hearing-impairment-in-children-evaluation\" class=\"medical medical_review\">Hearing impairment in children: Evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=herpes-simplex-virus-type-1-encephalitis\" class=\"medical medical_review\">Herpes simplex virus type 1 encephalitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=human-ehrlichiosis-and-anaplasmosis\" class=\"medical medical_review\">Human ehrlichiosis and anaplasmosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immunizations-for-travel\" class=\"medical medical_review\">Immunizations for travel</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infection-prevention-precautions-for-preventing-transmission-of-infection\" class=\"medical medical_review\">Infection prevention: Precautions for preventing transmission of infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Management and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cytomegalovirus-infections-in-children\" class=\"medical medical_review\">Overview of cytomegalovirus infections in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=paraneoplastic-and-autoimmune-encephalitis\" class=\"medical medical_review\">Paraneoplastic and autoimmune encephalitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=meningitis-in-children-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Meningitis in children (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=meningitis-in-children-the-basics\" class=\"medical medical_basics\">Patient education: Meningitis in children (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=viral-meningitis-the-basics\" class=\"medical medical_basics\">Patient education: Viral meningitis (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=poliovirus-vaccination\" class=\"medical medical_review\">Poliovirus vaccination</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-arthropod-and-insect-bites-repellents-and-other-measures\" class=\"medical medical_review\">Prevention of arthropod and insect bites: Repellents and other measures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rabies-immune-globulin-and-vaccine\" class=\"medical medical_review\">Rabies immune globulin and vaccine</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-and-treatment-with-antiviral-drugs\" class=\"medical medical_review\">Seasonal influenza in children: Prevention and treatment with antiviral drugs</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-with-vaccines\" class=\"medical medical_review\">Seasonal influenza in children: Prevention with vaccines</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=toxoplasmosis-in-immunocompetent-hosts\" class=\"medical medical_review\">Toxoplasmosis in immunocompetent hosts</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-west-nile-virus-infection\" class=\"medical medical_review\">Treatment and prevention of West Nile virus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-herpes-zoster-in-the-immunocompetent-host\" class=\"medical medical_review\">Treatment of herpes zoster in the immunocompetent host</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=trichinellosis\" class=\"medical medical_review\">Trichinellosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=viral-meningitis-clinical-features-and-diagnosis-in-children\" class=\"medical medical_review\">Viral meningitis: Clinical features and diagnosis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=viral-meningitis-epidemiology-pathogenesis-and-etiology-in-children\" class=\"medical medical_review\">Viral meningitis: Epidemiology, pathogenesis, and etiology in children</a></li></ul></div></div>","javascript":null}